Association of docetaxel/paclitaxel with irradiation in ovarian carcinoma cell lines in bidimensional (sulforhodamine B assay) and tridimensional (spheroids) cultures

被引:9
作者
GriffonEtienne, G
Merlin, JL
Marchal, C
机构
[1] CTR ALEXIS VAUTRIN,LAB RECH ONCOL,F-54511 VANDOEUVRE NANCY,FRANCE
[2] CTR ALEXIS VAUTRIN,SERV RADIOTHERAPIE,F-54511 VANDOEUVRE NANCY,FRANCE
关键词
docetaxel; irradiation; multicellular tumor spheroid; ovarian tumor; paclitaxel; sulforhodamine B;
D O I
10.1097/00001813-199608000-00007
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The association of taxoid derivatives (paclitaxel and docetaxel) with irradiation was evaluated in ovarian carcinoma cell lines (A2780 and CAVEOC-2) using the multicellular tumor spheroids (MTS) tridimensional model and compared to the conventional bidimensional model. The radiosensitivity parameters were the surviving fraction at 2 Gy, and alpha calculated using the linear-quadratic model for monolayer culture, the residual/control volume ratios at 2 Gy (RSV(2)) acid doses inducing 50% decrease in MTS number (SCD50) calculated for spheroids. In A2780 monolayer culture, the combination was synergistic for paclitaxel and additive for docetaxel. In spheroids, both compounds induced a decrease in RSV(2) and SCD50 in the two cell lines, and their combination with radiation was additive. Therefore, the radiosensitizing effect of taxoid derivatives was not constant in ovarian cell lines. The different results achieved in monolayer culture and in spheroids may suggest higher drug incorporation and fixation through the multiple cell layers of the spheroids than in monolayers.
引用
收藏
页码:660 / 670
页数:11
相关论文
共 39 条
[1]  
BISSERY MC, 1991, CANCER RES, V51, P4845
[2]   DOCETAXEL (TAXOTERE(R)) - A REVIEW OF PRECLINICAL AND CLINICAL-EXPERIENCE .1. PRECLINICAL EXPERIENCE [J].
BISSERY, MC ;
NOHYNEK, G ;
SANDERINK, GJ ;
LAVELLE, F .
ANTI-CANCER DRUGS, 1995, 6 (03) :339-355
[3]   QUANTITATIVE-ANALYSIS OF DOSE-EFFECT RELATIONSHIPS - THE COMBINED EFFECTS OF MULTIPLE-DRUGS OR ENZYME-INHIBITORS [J].
CHOU, TC ;
TALALAY, P .
ADVANCES IN ENZYME REGULATION, 1984, 22 :27-55
[4]  
CHOY H, 1992, Proceedings of the American Association for Cancer Research Annual Meeting, V33, P500
[5]  
COLEMAN CN, 1993, RADIOTHER ONCOL, V28, P1
[6]   DISTRIBUTION AND ACTIVITY OF ANTINEOPLASTIC DRUGS IN A TUMOR-MODEL [J].
DURAND, RE .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1989, 81 (02) :146-152
[7]   RELATIONS BETWEEN THE PENETRATION, BINDING AND AVERAGE CONCENTRATION OF CYTOSTATIC DRUGS IN HUMAN TUMOR SPHEROIDS [J].
ERLANSON, M ;
DANIELSZOLGAY, E ;
CARLSSON, J .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1992, 29 (05) :343-353
[8]   INHERENT CELLULAR RADIOSENSITIVITY AS A BASIC CONCEPT FOR HUMAN-TUMOR RADIOTHERAPY [J].
FERTIL, B ;
MALAISE, EP .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1981, 7 (05) :621-629
[9]   RADIATION AND TAXOL EFFECTS ON SYNCHRONIZED HUMAN CERVICAL-CARCINOMA CELLS [J].
GEARD, CR ;
JONES, JM .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1994, 29 (03) :565-569
[10]  
GILLESPIE CJ, 1975, RADIAT RES, V64, P353, DOI 10.2307/3574271